SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-089566
Filing Date
2023-08-10
Accepted
2023-08-10 07:40:17
Documents
14
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2323072d1_8k.htm   iXBRL 8-K 26342
2 EXHIBIT 99.1 tm2323072d1_ex99-1.htm EX-99.1 82517
6 GRAPHIC tm2323072d1_ex99-1img01.jpg GRAPHIC 4502
  Complete submission text file 0001104659-23-089566.txt   303641

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mist-20230810.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mist-20230810_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mist-20230810_pre.xml EX-101.PRE 22373
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2323072d1_8k_htm.xml XML 3561
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 231157213
SIC: 2834 Pharmaceutical Preparations